C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2011
10/13/2011	WO2011124704A1 Process for preparing an intermediate for silodosin
10/13/2011	US20110251254 Novel salt of tegaserod
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251193 1,2-benzisothiazolinone and isoindolinone derivatives
10/13/2011	US20110251188 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110250137 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/13/2011	CA2795085A1 Indolyl or indolinyl hydroxamate compounds
10/12/2011	EP2374792A1 N-substituted benzene sulfonamides
10/12/2011	EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic
10/12/2011	EP2373619A1 Geminal alkoxy/alkylspirocyclic substituted tetramic acid derivates
10/12/2011	EP2373618A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
10/12/2011	EP2373349A1 Dye conjugate imaging agents
10/12/2011	EP2265583B1 Spiroindolinone derivatives
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN1702065B Fluorene-based compound and organic electroluminescent display device using the same
10/12/2011	CN102216321A Therapeutic antiviral peptides
10/12/2011	CN102216269A Novel compound and organic electronic device using same
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102216260A Amino acid derivative
10/12/2011	CN102216256A Enantioselective synthesis of gamma-amino-alpha,beta-unsaturated carboxylic acid derivative
10/12/2011	CN102214795A Organic light-emitting device
10/12/2011	CN102212030A Substituted tetrahydrocarbazole antifungal compounds and preparation method thereof
10/12/2011	CN102212029A Synthesis method of disperse blue 60 intermediate
10/12/2011	CN102212028A Preparation method of (L)-5-hydroxytryptophan
10/12/2011	CN102212027A Preparation method for sumatriptan
10/12/2011	CN101415680B Benzoisoindole derivatives for the treatment of pain
10/12/2011	CN101198326B Combined pharmaceutical preparation for treatment of type 2 diabetes
10/11/2011	US8034960 Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as cPLA2 inhibitors
10/11/2011	US8034907 Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
10/11/2011	US8034837 Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
10/11/2011	US8034824 Iontophoretic preparation for treatment of breast cancer and/or mastitis
10/11/2011	US8034807 Salts of bazedoxifene
10/11/2011	US8034806 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
10/11/2011	CA2575912C Process for the preparation of optically pure indoline-2-carboxylic acid
10/11/2011	CA2555216C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2318273C Compound for use as a mineral fibre binder and process for providing such
10/06/2011	WO2011123536A1 Polycyclic tetracycline compounds
10/06/2011	WO2011122991A1 Indole derivative with antihypertensive effect and method for producing same
10/06/2011	WO2011121629A1 Indolic derivatives and use thereof in medical field
10/06/2011	WO2011120912A1 Fungicidal iminoderivatives
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	US20110245477 Efficient methods for z- or cis-selective cross-metathesis
10/06/2011	US20110245429 Cross Linked Organic Conductive Layer
10/06/2011	US20110245315 Indolyl or indolinyl hydroxamate compounds
10/06/2011	US20110245210 Thalidomide analogs
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110240978 Heterocyclic compound and organic light-emitting device including the same
10/06/2011	CA2799727A1 Polycyclic tetracycline compounds
10/05/2011	EP2371904A1 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371421A1 Ligands of insulin degrading enzyme and their uses
10/05/2011	EP2371219A1 Herbicidal acylhydrazides
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2370406A1 High penetration compositions and their applications
10/05/2011	EP2370405A1 Triple reuptake inhibitors and methods of their use
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	CN102209711A Compounds for the treatment of hepatitis c
10/05/2011	CN102206206A Azabicyclooctane hydroximic acid derivatives, preparation method thereof, and application thereof in medicament
10/05/2011	CN102206161A Diamine, polymer obtained from reaction with the presence of the diamine, liquid crystal aligning agent containing the polymer, liquid crystal alignment layer and liquid crystal display device
10/05/2011	CN101531686B Monomer for organic electrophosphorescent polymer
10/05/2011	CN101351446B Novel fused pyrrole derivatives
10/04/2011	US8030500 Substituted isoindoles for the treatment and/or prevention of Aβ- related pathologies
10/04/2011	US8030499 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
10/04/2011	US8030343 Phosphodiesterase inhibitor; tumor necrosis factor antagonist; autoimmune diseases; sepsis; malaria ; skin disorders; anticancer agents; antiarthritic agents; Crohn's disease; inflammatory bowel disorders
10/04/2011	US8029767 Fluorescent membrane intercalating probes and methods for their use
10/04/2011	CA2507505C N-arylsulfonyl-3-aminoalkoxyindoles
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/2011
09/29/2011	WO2011118818A1 Amidinoaneline derivative
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011117798A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
09/29/2011	WO2011117421A1 Tricyclic indole derivatives as pbr ligands
09/29/2011	WO2011043568A3 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
09/29/2011	WO2011030330A3 Process for the purification of ropinirole hydrochloride
09/29/2011	US20110237794 Spiro Compounds And Methods Of Use
09/29/2011	US20110237776 Aromatic compounds with sulfur containing ligands
09/29/2011	US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
09/29/2011	US20110237559 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1
09/29/2011	US20110236434 Polymorphic Forms of ST-246 and Methods of Preparation
09/29/2011	US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor
09/29/2011	CA2793533A1 Polymorphic forms of st-246 and methods of preparation
09/29/2011	CA2792394A1 Tricyclic indole derivatives as pbr ligands
09/29/2011	CA2790139A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
09/28/2011	EP2368901A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368878A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors
09/28/2011	EP2367817A1 Inhibitors of diacylglycerol acyltransferase
09/28/2011	EP2367792A1 Methods for producing and purifying 2-aryl-3, 3-bis ( 4 -hydroxyaryl) phthalimidine derivatives
09/28/2011	EP2367791A1 Perindopril tosylate
09/28/2011	EP2367790A2 Substituted octahydrocyclopenta(c)pyrrol-4-amines as calcium channel blockers
09/28/2011	CN1795174B Novel substituted 3-sulfur indoles
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203136A Photoinitiator mixtures
09/28/2011	CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
09/28/2011	CN102203063A Carbazole compounds and therapeutic uses of the compounds
09/28/2011	CN102203056A Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof

1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 458